Capsugel will provide nano-encryption for capsules through technology license
Pharma service providers and contract manufacturing organizations continue to create new options for drugmakers seeking to protect their products against counterfeiting. While most of these techniques apply to packaging and labels, there seems to be a trend developing in “on dosage” techniques applied directly to tablets or capsules.
The latest: Capsugel (Peapack, NJ), a division of Pifzer, has announced a licensing agreement with NanoGuardian (Skokie, IL) to employ the latter’s nanoscale marking technology on capsules. Nanoguardian has been promoting this technology for the past couple years as a means of not only putting overt (but hard to duplicate) markings on tablets, but also covert identification data, such as a lot number, within the overt marking. There are no additional materials, such as taggants, added to the marking, and the company claims that the technology costs less than a penny per pill.
Capsugel is the first company to apply this level of authentication to capsules, according to a company spokesperson. “We will provide the encoded capsules, then manufacturers will use them in their own filling operations,” says Alyssa Augustine, director of communications at Capsugel. The company is in the process of acquiring an encryption machine that will be added to one of its production lines, and clients can order batches of encoded capsules, in lot sizes up to one million, with each lot having a unique marking. Production is expected to be ready by the middle of this year.
Last summer, Colorcon (Harleyville, PA), a leading provider of coatings and excipients for tablets, announced a similar partnering with ARmark Technologies (Glen Rock, PA), which has developed nano-scale microtaggants that can be added to the coatings that Colorcon sells; ARmark calls the technology On-Dose ID. This announcement came right after FDA issued draft guidance on “physical-chemical identifiers” (PCIDs), generally allowing their use as long as the PCIDs are inert.
Colorcon has a Brand Enhancement Service that includes using specialized pigments as counterfeit-resistant measures; even adding barcodes to a tablet surface. Similarly, Merck KGaA (Darmstadt, Germany) has been promoting its Candurin coatings with the same capability.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.